Recombinant Vaccinia Virus Expressing the Herpes Simplex Virus Type 1 Glycoprotein C Protects Mice against Herpes Simplex Virus Challenge

References

1. Cantin E. M., Eberle R., Baldick J. L., Moss B., Willey D. E., Notkins A. L., Openshaw H. 1987; Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proceedings of the National Academy of SciencesU.S.A 84:5908–5912
   [Google Scholar]
2. Coupar B. E. H., Andrew B. M. E., Both G. W., Boyle D. B. 1986; Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. European Journal of Immunology 16:1479–1487
   [Google Scholar]
3. Cremer K. J., Mackett M., Wohlenberg C., Notkins A. L., Moss B. 1985; Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737–740
   [Google Scholar]
4. Eberle R., Courtney R. J. 1978; Assay of type-specific and type-common antibodies to herpes simplex virus type 1 and 2 in human sera. Infection and Immunity 31:1062–1070
   [Google Scholar]
5. Elkins K. L., Stashak P. W., Baker P. I. 1987; Cell-associated IgM, but not IgD or IgA/E, is important in the activation of suppressor T cells by antigen-primed B cells. Journal of Immunology 139:695–701
   [Google Scholar]
6. Frink R. J., Eisenberg R., Cohen G., Wagner E. K. 1983; Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. Journal of Virology 45:634–647
   [Google Scholar]
7. Glorioso J., SchröDer C. H., Kumel G., Szczesiul M., Levine M. 1984; Immunogenicity of herpes simplex glycoproteins gC and gB and their role in protective immunity. Journal of Virology 50:805–812
   [Google Scholar]
8. Glorioso J., Kees U., Kumel G., Kirchner H., Krammer P. H. 1985; Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for the HSV-1-specific memory cytotoxic T lymphocytes. Journal of Immunology 135:575–582
   [Google Scholar]
9. Hiernaux J. R., Goidl E. A., Martin Mcevoy S. J., Stashak P. W., Baker P. J., Holmes K. L. 1989; Characterization of the immunodeficiency of RIIIS/J mice. I. Association with the CD5 (Ly-1) B cell lineage. Journal of Immunology 142:1813–1817
   [Google Scholar]
10. Joklik W. K. 1962; The purification of four strains of poxvirus. Virology 18:9–18
    [Google Scholar]
11. Koga J., Chatterjee S., Whitley R. J. 1986; Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology 151:385–389
    [Google Scholar]
12. Kunkel T. A., Roberts J. D., Zakour R. A. 1987; Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods in Enzymology 154:367–381
    [Google Scholar]
13. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227680–685
    [Google Scholar]
14. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
15. Maniatis T., Fritsch E. F., Sambrook J. 1982; . Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
16. Martin S., Rouse B. T. 1987; The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. Journal of Immunology 138:3431–3437
    [Google Scholar]
17. Martin S., Cantin E., Rouse B. T. 1989; Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex type 1 glycoproteins. Journal of General Virology 70:1359–1370
    [Google Scholar]
18. Moss B., Flexner C. 1987; Vaccinia virus expression vectors. Annual Review of Immunology 5:305–324
    [Google Scholar]
19. Paoletti E., Lipinskas B. R., Samsonoff C., Mercer S., Panicali D. 1984; Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences: U.S.A; 81193–197
    [Google Scholar]
20. Roberts P. L., Duncan B. E., Raybould T. J. G., Watson D. H. 1985; Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Journal of General Virology 66:1073–1085
    [Google Scholar]
21. Schrier R. D., Pizer L. I., Moorhead J. W. 1983; Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. Journal of Immunology 130:1413–1418
    [Google Scholar]
22. Show Alter S. D., Zweig M., Hampar B. 1981; Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP4. Infection and Immunity 34:684–692
    [Google Scholar]
23. Spear P. G. 1985; Glycoproteins specified by herpes simplex virus. In The Herpesviruses 3315–356 Roizman B. New York: Plenum Press;
    [Google Scholar]
24. Sullivan V., Smith G. L. 1987; Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody. Journal of General Virology 68:2587–2598
    [Google Scholar]
25. Sullivan V., Smith G. L. 1988; The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization. Journal of General Virology 69:859–867
    [Google Scholar]
26. Turtinen L. W., Lathey J. L., Rouse B. T. 1986; Estimation of the B lymphocyte precursor frequency to herpes simplex type 1 glycoproteins by a limiting dilution assay. Journal of Medical Virology 20:357–362
    [Google Scholar]
27. Zagursky R., Baumeister N., Lomax N., Berman M. 1985; Rapid and easy sequencing of large linear double-stranded DNA and supercoiled plasmid DNA. Gene Analysis Techniques 2:89–94
    [Google Scholar]